Chat and email work, but replies take about a day
FDA has issued a box warning of the risk of thyroid cancers and are contraindicated liraglutide, exenatide (once weekly), and semaglutide (both oral and injectable) in patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia types 2 A or 2B [135, 136]
Considerations Favoring Oral Formats Oral supplements have a longer research history with more established dosing protocols
Wegovy comes in 5 different doses: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg
Vyleesi is administered as a 1.75 mg subcutaneous injection taken as needed at least 45 minutes before anticipated sexual activity, with a maximum frequency of one dose per 24 hours and no more than eight doses per month